Leddy et al., 1977 - Google Patents
Effect of selective complement deficiency on the rate of neutralization of enveloped viruses by human seraLeddy et al., 1977
View PDF- Document ID
- 7870317180478154986
- Author
- Leddy J
- Simons R
- Douglas R
- Publication year
- Publication venue
- The Journal of Immunology
External Links
Snippet
The capacity of human sera genetically deficient in selective complement (C) components to enhance neutralization of enveloped viruses was examined by kinetic plaque reduction assays. Vaccinia virus, a DNA virus, and vesicular stomatitis virus (VSV), an RNA virus, were …
- 241000700605 Viruses 0 title abstract description 70
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
- C07K16/1036—Retroviridae, e.g. leukemia viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Leddy et al. | Effect of selective complement deficiency on the rate of neutralization of enveloped viruses by human sera | |
Perrin et al. | Mechanism of injury of virus-infected cells by antiviral antibody and complement: participation of IgG, F (ab') 2, and the alternative complement pathway. | |
Mitra et al. | Elimination of infectious retroviruses during preparation of immunoglobulins | |
ES2476416T3 (en) | Composition of intravenous immunoglobulin | |
Rotbart et al. | Persistent enterovirus infection in culture-negative meningoencephalitis: demonstration by enzymatic RNA amplification | |
Garcia-Fuentes et al. | Cryoglobulinaemia in Henoch-Schönlein purpura. | |
Laiwah et al. | Lymphocyte transforamtion and leucocyte migration–inhibition by Australia antigen | |
Snyder Jr et al. | Specificities of human immunoglobulins reactive with antigens in preparations of several mammalian type-C viruses | |
Hart et al. | Effect of terminal (dry) heat treatment on non-enveloped viruses in coagulation factor concentrates | |
Schmidt et al. | Characterization of antibodies produced in natural and experimental coxsackievirus infections | |
Miller et al. | Infectious mononucleosis: appearance of neutralizing antibody to Epstein-Barr virus measured by inhibition of formation of lymphoblastoid cell lines | |
Tedesco et al. | A familial dysfunction of the eighth component of complement (C8) | |
JP2537850B2 (en) | Manufacturing method of immunoglobulin without retrovirus | |
JPH06509866A (en) | Method of screening plasma samples for effective antibody titers against respiratory viruses | |
Mills et al. | Antibody-independent neutralization of vesicular stomatitis virus by human complement: I. Complement requirements | |
Garcia-Tapia et al. | Spectrum of parvovirus B19 infection: analysis of an outbreak of 43 cases in Cadiz, Spain | |
Gard et al. | Hemagglutination by Col-MM-virus | |
Weller | Varicella—Herpes Zoster Virus | |
TINDALL et al. | Serum antibodies to cytomegalovirus in myasthenia gravis: effects of thymectomy and steroids | |
Zaia et al. | A practical method for preparation of varicella-zoster immune globulin | |
Sköldenberg et al. | Transient appearance of oligoclonal immunoglobulins and measles virus antibodies in the cerebrospinal fluid in a case of acute measles encephalitis. | |
FISCUS et al. | Infectious immune complexes in HIV-1-infected patients | |
Pincus et al. | Reactivities of systemic lupus erythematosus sera with cellular and virus antigen preparations | |
Sallay et al. | Immunofluorescent studies on circulating lymphocytes in oral mucosal diseases | |
Collins et al. | Normal chicken cells (chf−) express a surface antigen which cross-reacts with determinants of the major envelope glycoprotein (gp85) of avian myeloblastosis virus |